CHMP Opinions: Opdivo Sees Keytruda's Hodgkin's And Raises It Head & Neck
Executive Summary
Merck & Co and Bristol Myers Squibb's rival anti-PD1 products continue their game of one-upmanship with each gaining a new indication in the latest round of EU CHMP opinions.